{"protocolSection": {"identificationModule": {"nctId": "NCT02271230", "orgStudyIdInfo": {"id": "2014P001206"}, "organization": {"fullName": "Brigham and Women's Hospital", "class": "OTHER"}, "briefTitle": "Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure", "officialTitle": "Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure"}, "statusModule": {"statusVerifiedDate": "2022-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-08"}, "primaryCompletionDateStruct": {"date": "2019-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-10-07", "studyFirstSubmitQcDate": "2014-10-21", "studyFirstPostDateStruct": {"date": "2014-10-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2022-02-23", "resultsFirstSubmitQcDate": "2022-02-23", "resultsFirstPostDateStruct": {"date": "2022-03-18", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-02-23", "lastUpdatePostDateStruct": {"date": "2022-03-18", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Luc Djousse", "investigatorTitle": "Director of Research, Associate Professor of Medicine", "investigatorAffiliation": "Brigham and Women's Hospital"}, "leadSponsor": {"name": "Brigham and Women's Hospital", "class": "OTHER"}}, "descriptionModule": {"briefSummary": "This study will examine whether an intervention with vitamin D or fish oil supplements can reduce the risk of heart failure among adult men and women during a follow up period of up to five years (starting from the time of randomization into the parent VITAL trial). The investigators hypotheses are that both vitamin D and fish oil supplements will each reduce the risk of heart failure.", "detailedDescription": "For this ancillary study of the ongoing parent VITAL trial, we will adjudicate incident heart failure cases occurring during a time period of up to five years starting from randomization of subjects in the parent VITAL study. Intention-to-treat analysis will be used to assess the efficacy of vitamin D as well as omega-3 fatty acids."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "FACTORIAL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 25871, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Vitamin D and fish oil", "type": "EXPERIMENTAL", "description": "2000 IU per day and 1 g per day of fish oil", "interventionNames": ["Drug: Vitamin D and fish oil"]}, {"label": "Vitamin D alone", "type": "PLACEBO_COMPARATOR", "description": "2000 IU Vitamin D and fish oil placebo", "interventionNames": ["Drug: Vitamin D alone"]}, {"label": "Fish oil (EPA/DHA) alone", "type": "EXPERIMENTAL", "description": "1 g per day of fish oil and vitamin D placebo", "interventionNames": ["Dietary Supplement: Fish oil (EPA/DHA) alone"]}, {"label": "Fish oil and vitamin D placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo for both vitamin D and fish oil", "interventionNames": ["Other: Placebo"]}], "interventions": [{"type": "DRUG", "name": "Vitamin D and fish oil", "description": "2000 IU vitamin D and 1g/d fish oil", "armGroupLabels": ["Vitamin D and fish oil"]}, {"type": "DIETARY_SUPPLEMENT", "name": "Fish oil (EPA/DHA) alone", "description": "1 g/d fish oil", "armGroupLabels": ["Fish oil (EPA/DHA) alone"]}, {"type": "DRUG", "name": "Vitamin D alone", "description": "2000 IU vitamin D", "armGroupLabels": ["Vitamin D alone"]}, {"type": "OTHER", "name": "Placebo", "description": "Vitamin D placebo and fish oil placebo", "armGroupLabels": ["Fish oil and vitamin D placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants With New Heart Failure Hospitalization", "description": "We will consider any hospitalization for heart failure among participants enrolled in the parent VITAL trial for this ancillary study. Incident heart failure are initially captured through annual questionnaires with subsequent validation by a team of physicians with expertise in cardiovascular medicine and epidemiology. We excluded 36 participants with prevalent heart failure at the time of randomization for the primary analysis.", "timeFrame": "5 years"}], "secondaryOutcomes": [{"measure": "Number of Recurrent Heart Failure Hospitalization", "description": "Recurrent heart failure hospitalizations ascertained either by review of medical records and/or use of CMS (Center for Medicare and Medicaid Services) data.", "timeFrame": "5 years"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Men aged 50 or older or women aged 55 or older\n* Be consuming no more than 800 IU of vitamin D from all supplemental sources combined (individual vitamin D supplements, calcium+vitamin D supplements, medications with vitamin D \\[e.g., Fosamax Plus D\\], and multivitamins), or, if taking, willing to decrease or forego such use during the trial;\n* Be consuming no more than 1200 mg/d of calcium from all supplemental sources combined, or, if taking, willing to decrease or forego such use during the trial;\n* Not be taking fish oil supplements, or, if taking, willing to forego their use during the trial\n\nExclusion Criteria:\n\n* prevalent heart failure\n* History of cancer (except non-melanoma skin cancer), heart attack, stroke, transient ischemic attack, angina pectoris, CABG, or PCI\n* History of renal failure or dialysis, hypercalcemia, hypo- or hyperparathyroidism, severe liver disease (cirrhosis), or sarcoidosis or other granulomatous diseases such as active chronic tuberculosis or Wegener's granulomatosis;\n* Allergy to fish or soy", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "50 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Brigham and Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02120", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "The trial included a 3-month placebo run-in period to select participants likely to have excellent compliance. Only individuals who reported taking at least 2/3 of their study pills during the run-in and met other eligibility criteria were randomized into the trial.", "recruitmentDetails": "A total of 401605 adults were initially screened; 39430 eligible to enter run-in; 25871 eligible for randomization; 2x2 factorial design: 12927 assigned to active vit D (of these, 6463 were assigned to active omega-3 FAs and 6464 to placebo omega-3 FAs) \\& 12944 assigned to placebo vit D (of these, 6470 were assigned to active omega-3 FAs and 6474 to placebo omega-3 FAs)", "groups": [{"id": "FG000", "title": "Active Vitamin D + Active Omega-3 Fatty Acids", "description": "Active Vitamin D = Vitamin D3, one 2000 IU capsule/day; Active Omega-3 Fatty Acids = Omacor, one 1-gram capsule/day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \\[EPA\\] and 375 mg of docosahexaenoic acid \\[DHA\\])."}, {"id": "FG001", "title": "Active Vitamin D + Placebo Omega-3 Fatty Acids", "description": "Active Vitamin D = Vitamin D3, one 2000 IU capsule/day; Placebo Omega-3 Fatty Acids, one capsule/day"}, {"id": "FG002", "title": "Placebo Vitamin D + Active Omega-3 Fatty Acids", "description": "Placebo Vitamin D, one capsule/day; Active Omega-3 Fatty Acids = Omacor, one 1-gram capsule/day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \\[EPA\\] and 375 mg of docosahexaenoic acid \\[DHA\\])."}, {"id": "FG003", "title": "Placebo Vitamin D + Placebo Omega-3 Fatty Acids", "description": "Placebo Vitamin D, one capsule/day; Placebo Omega-3 Fatty Acids, one capsule/day"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6463"}, {"groupId": "FG001", "numSubjects": "6464"}, {"groupId": "FG002", "numSubjects": "6470"}, {"groupId": "FG003", "numSubjects": "6474"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6463"}, {"groupId": "FG001", "numSubjects": "6464"}, {"groupId": "FG002", "numSubjects": "6470"}, {"groupId": "FG003", "numSubjects": "6474"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Baseline characteristics of participants enrolled in the VITAL-Heart Failure ancillary study stratified by randomization arm", "groups": [{"id": "BG000", "title": "Active Vitamin D + Active Omega-3 Fatty Acids", "description": "Active Vitamin D = Vitamin D3, one 2000 IU capsule/day; Active Omega-3 Fatty Acids = Omacor, one 1-gram capsule/day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \\[EPA\\] and 375 mg of docosahexaenoic acid \\[DHA\\])."}, {"id": "BG001", "title": "Active Vitamin D + Placebo Omega-3 Fatty Acids", "description": "Active Vitamin D = Vitamin D3, one 2000 IU capsule/day; Placebo Omega-3 Fatty Acids, one capsule/day"}, {"id": "BG002", "title": "Placebo Vitamin D + Active Omega-3 Fatty Acids", "description": "Placebo Vitamin D, one capsule/day; Active Omega-3 Fatty Acids = Omacor, one 1-gram capsule/day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \\[EPA\\] and 375 mg of docosahexaenoic acid \\[DHA\\])."}, {"id": "BG003", "title": "Placebo Vitamin D + Placebo Omega-3 Fatty Acids", "description": "Placebo Vitamin D, one capsule/day; Placebo Omega-3 Fatty Acids, one capsule/day"}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6463"}, {"groupId": "BG001", "value": "6464"}, {"groupId": "BG002", "value": "6470"}, {"groupId": "BG003", "value": "6474"}, {"groupId": "BG004", "value": "25871"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6463"}, {"groupId": "BG001", "value": "6464"}, {"groupId": "BG002", "value": "6470"}, {"groupId": "BG003", "value": "6474"}, {"groupId": "BG004", "value": "25871"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "67.1", "spread": "7.1"}, {"groupId": "BG001", "value": "67.1", "spread": "7.0"}, {"groupId": "BG002", "value": "67.2", "spread": "7.1"}, {"groupId": "BG003", "value": "67.1", "spread": "7.1"}, {"groupId": "BG004", "value": "67.1", "spread": "7.1"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6463"}, {"groupId": "BG001", "value": "6464"}, {"groupId": "BG002", "value": "6470"}, {"groupId": "BG003", "value": "6474"}, {"groupId": "BG004", "value": "25871"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "3276"}, {"groupId": "BG001", "value": "3271"}, {"groupId": "BG002", "value": "3271"}, {"groupId": "BG003", "value": "3267"}, {"groupId": "BG004", "value": "13085"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "3187"}, {"groupId": "BG001", "value": "3193"}, {"groupId": "BG002", "value": "3199"}, {"groupId": "BG003", "value": "3207"}, {"groupId": "BG004", "value": "12786"}]}]}]}, {"title": "Race/Ethnicity, Customized", "description": "Not all participants reported race/ethnicity", "populationDescription": "Not all participants provided information on race/ethnicity; hence the discrepancy between number reported under race/ethnicity and total number enrolled.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "count", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6329"}, {"groupId": "BG001", "value": "6318"}, {"groupId": "BG002", "value": "6324"}, {"groupId": "BG003", "value": "6333"}, {"groupId": "BG004", "value": "25304"}]}], "categories": [{"title": "Non-Hispanic White", "measurements": [{"groupId": "BG000", "value": "4515"}, {"groupId": "BG001", "value": "4498"}, {"groupId": "BG002", "value": "4529"}, {"groupId": "BG003", "value": "4504"}, {"groupId": "BG004", "value": "18046"}]}, {"title": "African American", "measurements": [{"groupId": "BG000", "value": "1278"}, {"groupId": "BG001", "value": "1275"}, {"groupId": "BG002", "value": "1271"}, {"groupId": "BG003", "value": "1282"}, {"groupId": "BG004", "value": "5106"}]}, {"title": "Hispanic (not African American)", "measurements": [{"groupId": "BG000", "value": "246"}, {"groupId": "BG001", "value": "270"}, {"groupId": "BG002", "value": "245"}, {"groupId": "BG003", "value": "252"}, {"groupId": "BG004", "value": "1013"}]}, {"title": "Asian/Pacific Islander", "measurements": [{"groupId": "BG000", "value": "102"}, {"groupId": "BG001", "value": "86"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "102"}, {"groupId": "BG004", "value": "388"}]}, {"title": "Native American/Alaskan Native", "measurements": [{"groupId": "BG000", "value": "62"}, {"groupId": "BG001", "value": "56"}, {"groupId": "BG002", "value": "58"}, {"groupId": "BG003", "value": "52"}, {"groupId": "BG004", "value": "228"}]}, {"title": "Other/Unknown", "measurements": [{"groupId": "BG000", "value": "126"}, {"groupId": "BG001", "value": "133"}, {"groupId": "BG002", "value": "123"}, {"groupId": "BG003", "value": "141"}, {"groupId": "BG004", "value": "523"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6463"}, {"groupId": "BG001", "value": "6464"}, {"groupId": "BG002", "value": "6470"}, {"groupId": "BG003", "value": "6474"}, {"groupId": "BG004", "value": "25871"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6463"}, {"groupId": "BG001", "value": "6464"}, {"groupId": "BG002", "value": "6470"}, {"groupId": "BG003", "value": "6474"}, {"groupId": "BG004", "value": "25871"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants With New Heart Failure Hospitalization", "description": "We will consider any hospitalization for heart failure among participants enrolled in the parent VITAL trial for this ancillary study. Incident heart failure are initially captured through annual questionnaires with subsequent validation by a team of physicians with expertise in cardiovascular medicine and epidemiology. We excluded 36 participants with prevalent heart failure at the time of randomization for the primary analysis.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Active Vitamin D", "description": "Vitamin D3, one 2000 IU capsule/day"}, {"id": "OG001", "title": "Vitamin D Placebo", "description": "Vitamin D placebo, one capsule/day"}, {"id": "OG002", "title": "Active Omega-3 Fatty Acids", "description": "Omacor, one 1-g capsule/day. Each capsule of Omacor contains 840 mg of marine omega-3 fatty acids (465 mg of EPA + 375 mg of DHA)."}, {"id": "OG003", "title": "Omega-3 Fatty Acids Placebo", "description": "Omega-3 fatty acids placebo, one capsule/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12904"}, {"groupId": "OG001", "value": "12931"}, {"groupId": "OG002", "value": "12912"}, {"groupId": "OG003", "value": "12923"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "240"}, {"groupId": "OG001", "value": "259"}, {"groupId": "OG002", "value": "244"}, {"groupId": "OG003", "value": "255"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "paramType": "Hazard Ratio (HR)", "paramValue": "0.93", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.78", "ciUpperLimit": "1.11"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "paramType": "Hazard Ratio (HR)", "paramValue": "0.96", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.80", "ciUpperLimit": "1.14"}]}, {"type": "SECONDARY", "title": "Number of Recurrent Heart Failure Hospitalization", "description": "Recurrent heart failure hospitalizations ascertained either by review of medical records and/or use of CMS (Center for Medicare and Medicaid Services) data.", "populationDescription": "Each participant is allowed to have multiple heart failure hospitalizations.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "hospitalizations for heart failure", "timeFrame": "5 years", "groups": [{"id": "OG000", "title": "Active Vitamin D", "description": "Vitamin D3, one 2000 IU capsule/day"}, {"id": "OG001", "title": "Vitamin D Placebo", "description": "Vitamin D placebo, one capsule/day"}, {"id": "OG002", "title": "Active Omega-3 Fatty Acids", "description": "Omacor, one 1-g capsule/day. Each capsule of Omacor contains 840 mg of marine omega-3 fatty acids (465 mg of EPA + 375 mg of DHA)."}, {"id": "OG003", "title": "Omega-3 Fatty Acids Placebo", "description": "Omega-3 fatty acids placebo, one capsule/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12927"}, {"groupId": "OG001", "value": "12944"}, {"groupId": "OG002", "value": "12933"}, {"groupId": "OG003", "value": "12938"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "341"}, {"groupId": "OG001", "value": "364"}, {"groupId": "OG002", "value": "326"}, {"groupId": "OG003", "value": "379"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "paramType": "Hazard Ratio (HR)", "paramValue": "0.94", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.81", "ciUpperLimit": "1.09"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "paramType": "Hazard Ratio (HR)", "paramValue": "0.86", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.74", "ciUpperLimit": "0.998"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "5 years", "description": "Conditions monitored for Vit D: kidney stones, hypercalcemia, parathyroid disease, kidney failure or dialysis; Other symptoms/side effects: gastrointestinal (GI) bleed, easy bruising; stomach upset or pain; nausea; constipation, diarrhea, skin rash Conditions monitored for omega-3: GI bleed; blood in urine; easy bruising; nosebleeds; kidney failure or dialysis; Other side effects: stomach upset or pain; nausea; constipation; diarrhea; skin rash; bad taste in mouth; increased burping", "eventGroups": [{"id": "EG000", "title": "Active Vitamin D", "description": "Vitamin D3, one capsule of 2,000 IU/day", "deathsNumAffected": 485, "deathsNumAtRisk": 12927, "seriousNumAffected": 1673, "seriousNumAtRisk": 12927, "otherNumAffected": 10086, "otherNumAtRisk": 12927}, {"id": "EG001", "title": "Vitamin D Placebo", "description": "Vitamin D placebo, 1 capsule/day", "deathsNumAffected": 493, "deathsNumAtRisk": 12944, "seriousNumAffected": 1659, "seriousNumAtRisk": 12944, "otherNumAffected": 10098, "otherNumAtRisk": 12944}, {"id": "EG002", "title": "Active Omega-3 Fatty Acids", "description": "Omacor, 1 g capsule/day Each capsule of Omacor contains 465 mg of eicosapentaenoic acid (EPA) and 375 mg of docosahexaenoic acid (DHA)", "deathsNumAffected": 493, "deathsNumAtRisk": 12933, "seriousNumAffected": 1613, "seriousNumAtRisk": 12933, "otherNumAffected": 10094, "otherNumAtRisk": 12933}, {"id": "EG003", "title": "Omega-3 Fatty Acids Placebo", "description": "Omega-3 fatty acids placebo, one capsule/day", "deathsNumAffected": 485, "deathsNumAtRisk": 12938, "seriousNumAffected": 1619, "seriousNumAtRisk": 12938, "otherNumAffected": 10090, "otherNumAtRisk": 12938}], "seriousEvents": [{"term": "Gastrointestinal bleeding", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 341, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 403, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 370, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 374, "numAtRisk": 12938}]}, {"term": "Hypercalcemia", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 147, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 143, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 151, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 139, "numAtRisk": 12938}]}, {"term": "Invasive cancer of any type", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 793, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 824, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 820, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 797, "numAtRisk": 12938}]}, {"term": "Death from cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 154, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 187, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 168, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 173, "numAtRisk": 12938}]}, {"term": "Breast cancer in women", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 124, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 122, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 117, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 129, "numAtRisk": 12938}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 192, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 219, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 219, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 192, "numAtRisk": 12938}]}, {"term": "Colorectal cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 51, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 47, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 54, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 44, "numAtRisk": 12938}]}, {"term": "Major cardiovascular events", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Composite of myocardial infarction, stroke, and cardiovascular death", "stats": [{"groupId": "EG000", "numAffected": 396, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 409, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 386, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 419, "numAtRisk": 12938}]}, {"term": "Myocardial infarction", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 169, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 176, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 145, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 200, "numAtRisk": 12938}]}, {"term": "Stroke", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 141, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 149, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 148, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 142, "numAtRisk": 12938}]}, {"term": "Death from cardiovascular causes", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 152, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 138, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 142, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 148, "numAtRisk": 12938}]}], "otherEvents": [{"term": "Easy bruising", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3434, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 3408, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 3443, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 3399, "numAtRisk": 12938}]}, {"term": "Frequent nosebleeds", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 466, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 490, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 465, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 491, "numAtRisk": 12938}]}, {"term": "Blood in urine", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 911, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 882, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 919, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 874, "numAtRisk": 12938}]}, {"term": "Parathyroid condition", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "hyperparathyroidism or hypoparathyroidism", "stats": [{"groupId": "EG000", "numAffected": 50, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 62, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 52, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 60, "numAtRisk": 12938}]}, {"term": "Stomach upset or pain", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4860, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 4870, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 4887, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 4843, "numAtRisk": 12938}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3519, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 3589, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 3558, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 3550, "numAtRisk": 12938}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5133, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 5162, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 5184, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 5111, "numAtRisk": 12938}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5511, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 5668, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 5599, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 5580, "numAtRisk": 12938}]}, {"term": "Increased burping", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2168, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 2207, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 2217, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 2158, "numAtRisk": 12938}]}, {"term": "Bad taste in mouth", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2195, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 2290, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 2240, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 2245, "numAtRisk": 12938}]}, {"term": "Kidney stones", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 477, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 426, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 430, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 473, "numAtRisk": 12938}]}, {"term": "Kidney failure or dialysis", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 85, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 88, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 85, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 88, "numAtRisk": 12938}]}, {"term": "Skin rash", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3268, "numAtRisk": 12927}, {"groupId": "EG001", "numAffected": 3430, "numAtRisk": 12944}, {"groupId": "EG002", "numAffected": 3331, "numAtRisk": 12933}, {"groupId": "EG003", "numAffected": 3367, "numAtRisk": 12938}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Luc Djousse", "organization": "Brigham and Women's Hospital", "email": "ldjousse@rics.bwh.harvard.edu", "phone": "617-525-7591"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2020-12-31", "uploadDate": "2022-02-23T20:25", "filename": "Prot_SAP_000.pdf", "size": 270077}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000014807", "term": "Vitamin D"}, {"id": "D000004872", "term": "Ergocalciferols"}, {"id": "D000002762", "term": "Cholecalciferol"}, {"id": "D000014815", "term": "Vitamins"}], "ancestors": [{"id": "D000018977", "term": "Micronutrients"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000050071", "term": "Bone Density Conservation Agents"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}], "browseLeaves": [{"id": "M17550", "name": "Vitamin D", "asFound": "Acid", "relevance": "HIGH"}, {"id": "M6003", "name": "Cholecalciferol", "asFound": "Acid", "relevance": "HIGH"}, {"id": "M17558", "name": "Vitamins", "asFound": "Period", "relevance": "HIGH"}, {"id": "M8026", "name": "Ergocalciferols", "asFound": "Acid", "relevance": "HIGH"}, {"id": "M21009", "name": "Micronutrients", "relevance": "LOW"}, {"id": "M16885", "name": "Trace Elements", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "T479", "name": "Vitamin D3", "asFound": "Acid", "relevance": "HIGH"}, {"id": "T442", "name": "Cholecalciferol", "asFound": "Acid", "relevance": "HIGH"}, {"id": "T440", "name": "Calciferol", "asFound": "Acid", "relevance": "HIGH"}, {"id": "T415", "name": "Omega 3 Fatty Acid", "relevance": "LOW"}, {"id": "T445", "name": "Ergocalciferol", "asFound": "Acid", "relevance": "HIGH"}, {"id": "T478", "name": "Vitamin D2", "asFound": "Acid", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}, {"abbrev": "Micro", "name": "Micronutrients"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Vi", "name": "Vitamins"}, {"abbrev": "Ot", "name": "Other Dietary Supplements"}]}}, "hasResults": true}